Delivery systems

US2024284917A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024284917-A1
Application numberUS-202218290538-A
CountryUS
Kind codeA1
Filing dateJun 28, 2022
Priority dateJun 30, 2021
Publication dateAug 29, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed herein are delivery systems which incorporate Moringa oleifera extract containing Moringa oleifera coagulation protein, therefore providing consumer products which contain natural extracts that provide antimicrobial benefits. Also disclosed herein are delivery systems including a carrier and a hydrophobic formulation, where the carrier includes Moringa oleifera coagulation protein (MOCP). Also disclosed herein are consumer products including the delivery system of the invention.

First claim

Opening claim text (preview).

1 . A delivery system comprising a carrier and a hydrophobic formulation, wherein the carrier comprises Moringa oleifera coagulation protein (MOCP). 2 . The delivery system of claim 1 , wherein the MOCP is in an extract from Moringa oleifera. 3 . The delivery system according to claim 1 , wherein the carrier is a core shell microcapsule. 4 . The delivery system according to claim 3 , wherein the MOCP is on an outside of the core shell microcapsule. 5 . The delivery system according to claim 2 , wherein MOCP is formulated within the core shell microcapsule. 6 . The delivery system of claim 3 wherein the core shell microcapsule comprises a material that is aminoplast-based, polyurea-based or polyurethane-based. 7 . The delivery system of claim 1 , wherein the carrier is a polymeric carrier matrix comprising a material selected from the group consisting of modified starch, maltodextrin, gums, proteins, polysaccharides and soluble fibers. 8 . The delivery system of claim 1 , wherein the delivery system is a polymeric carrier matrix comprising the polymeric shell. 9 . The delivery system of claim 1 , wherein the delivery system further comprises one or more emulsifying agents and/or antimicrobial agents. 10 . The delivery system according to claim 1 , wherein the delivery system is in the form of a spray-dried particle. 11 . The delivery system of claim 1 , wherein the extract from Moringa oleifera is present at an amount of 1% to 95% of the total weight of the delivery system. 12 . The delivery system of claim 1 , wherein the hydrophobic formulation comprises one or more active ingredient(s). 13 . The delivery system of claim 12 , wherein the active ingredient(s) is a perfume, flavor, dye, dye precursor, catalyst from chemical reactions, adhesive, reactive substance for adhesive applications, pharmaceutical active substance, preservative, cosmetic active substance, emollient, conditioner, palliative skin/hair product, plant protection active substance (for example insecticide, fungicide, herbicide, bacteriocide), water repellent, flame retardant, sunscreen agent, solvent or a food ingredient. 14 . A consumer product comprising the delivery system of claim 1 . 15 . The consumer product of claim 12 , wherein said product is a perfuming consumer product or a flavored consumer product. 17 . An antimicrobial agent comprising the delivery system of claim 1 . 18 . A method for reducing microbial growth, comprising incorporating the delivery system of claim 1 into a hygiene product for consumer use or into a food product.

Assignees

Inventors

Classifications

  • Preparations for cleaning the hair · CPC title

  • Encapsulated compositions · CPC title

  • Microcapsules {or nanocapsules} · CPC title

  • A01N25/10Primary

    Macromolecular compounds · CPC title

  • Disinfectants; Antimicrobial compounds or mixtures thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024284917A1 cover?
Disclosed herein are delivery systems which incorporate Moringa oleifera extract containing Moringa oleifera coagulation protein, therefore providing consumer products which contain natural extracts that provide antimicrobial benefits. Also disclosed herein are delivery systems including a carrier and a hydrophobic formulation, where the carrier includes Moringa oleifera coagulation protein (MO…
Who is the assignee on this patent?
Firmenich & Cie
What technology area does this patent fall under?
Primary CPC classification A01N25/10. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Aug 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).